NCT05475366 2026-02-18
PACsign
Institut Curie
Phase NA Recruiting
Clinical Trials
28 trialsNCT02750657 2025-11-18
COMPASS
University Health Network, Toronto
Completed
NCT07153289 2025-09-03
ResCPa
University Hospital Tuebingen
Phase 1/2 Not yet recruiting
NCT03856658 2025-06-17
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
Corewell Health West
Phase 2 Active not recruiting
NCT06813079 2025-02-18
Using Tumor Models to Determine Treatments
University Health Network, Toronto
Phase 2 Not yet recruiting
NCT06573398 2024-08-27
Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC
Ruijin Hospital
Phase 2 Not yet recruiting
NCT02310230 2024-06-25
An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy
University of Vermont
Phase NA Completed
NCT05621824 2024-04-09
A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS
Peking Union Medical College Hospital
Not yet recruiting
NCT04596865 2023-11-18
Recurrence After Whipple's (RAW) Study
University Hospital Plymouth NHS Trust
Completed
NCT03513705 2023-08-16
PACAP-1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT05723978 2023-02-13
Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study.
Tianjin Medical University Cancer Institute and Hospital
Completed
NCT04146441 2023-01-19
PDAC
St. Olavs Hospital
Phase 2 Completed
NCT05489458 2022-08-05
PF-BARNA
Hospital Universitari de Bellvitge
Unknown
NCT05095831 2022-01-04
EUS Shear Wave for Solid Pancreatic Lesions.
Instituto Ecuatoriano de Enfermedades Digestivas
Unknown
NCT03403101 2021-04-09
The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer
Fudan University
Phase 2 Unknown
NCT03500068 2021-01-19
OPT-1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Unknown
NCT00226746 2020-09-18
Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer
New York Presbyterian Brooklyn Methodist Hospital
Phase 2 Withdrawn
NCT02817308 2018-08-31
Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas
Rambam Health Care Campus
Phase NA Unknown
NCT03432624 2018-02-14
Detection of MicroRNA-25 in the Diagnosis of Pancreatic Cancer
Fudan University
Unknown
NCT02456051 2017-11-20
PaCANOD
University of Roma La Sapienza
Terminated
NCT02243007 2017-05-16
Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
Massachusetts General Hospital
Phase 2 Terminated
NCT02933307 2017-04-25
Continuous Monitoring on the General Ward
Radboud University Medical Center
Phase NA Completed
NCT02928081 2016-10-07
Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma
West China Hospital
Phase NA Unknown
NCT02150746 2016-02-23
Circulating Tumor Cells in Operative Blood
University of Florida
Completed
NCT02529579 2015-08-20
Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer
Changhai Hospital
Phase 1/2 Unknown
NCT02451384 2015-06-30
According CTC to Compare the Influences of Different Methods to Remove the PDAC
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT00588367 2015-04-15
CT Pancreas Perfusion
Mayo Clinic
Completed
NCT01394120 2012-03-27
Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer
Grupo Hospital de Madrid
Phase 2 Unknown